Northwire Canada EditionThursday, July 16, 2026
Northwire
LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.14 +0.0% NOBL 0.100 +0.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.45 +0.0% CAM 0.335 +0.0% SYH 0.405 +0.0% LOT 0.040 +0.0% CPL 0.190 +0.0% OTMC 0.400 +0.0% PEX 0.185 +0.0% TGOL 0.110 +0.0% TUNG 1.69 +0.0% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.14 +0.0% NOBL 0.100 +0.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.45 +0.0% CAM 0.335 +0.0% SYH 0.405 +0.0% LOT 0.040 +0.0% CPL 0.190 +0.0% OTMC 0.400 +0.0% PEX 0.185 +0.0% TGOL 0.110 +0.0% TUNG 1.69 +0.0%

Healthcare

Page 84
  1. Dec 17, 2025 · 21:19 · VPT

    Ventripoint to Issue Shares for Payment of Debenture Interest

    Ventripoint to Issue Shares for Payment of Debenture Interest

    01
  2. Dec 17, 2025 · 18:07 · UDOC

    Unidoc completes H3 Health Cube installation in Italy

    Unidoc completes H3 Health Cube installation in Italy

    02
  3. Dec 17, 2025 · 18:03 · LSL

    LSL Pharma to acquire Juno OTC for $5-million

    LSL Pharma to acquire Juno OTC for $5-million

    03
  4. Dec 17, 2025 · 18:01 · DTR

    DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

    DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

    04
  5. Dec 17, 2025 · 17:01 · VIVI

    TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida

    TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida

    05
  6. Dec 17, 2025 · 10:59 · BNXT

    Bionxt Solutions talks up sublingual thin-film product

    Bionxt Solutions talks up sublingual thin-film product

    06
  7. Dec 17, 2025 · 08:02 · BIOV

    BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer

    BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer

    07
  8. Dec 17, 2025 · 08:00 · UDOC

    UniDoc Completes H3 Health Cube Installation in Italy

    UniDoc Completes H3 Health Cube Installation in Italy

    08
  9. Dec 17, 2025 · 07:30 · LSL

    LSL PHARMA GROUP ANNOUNCES ACQUISITION OF JUNO OTC INC. AND A BROKERED PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURES OF $11M

    LSL PHARMA GROUP ANNOUNCES ACQUISITION OF JUNO OTC INC. AND A BROKERED PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURES OF $11M

    09
  10. Dec 17, 2025 · 07:25 · KNE

    Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

    Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

    10
  11. Dec 17, 2025 · 03:05 · BNXT

    Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film "Melt-in-Your-Mouth" Therapies

    Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film "Melt-in-Your-Mouth" Therapies

    11
  12. Dec 16, 2025 · 19:00 · NLH

    Nova Leap rolls out care management division in U.S.

    Nova Leap rolls out care management division in U.S.

    12
  13. Dec 16, 2025 · 18:32 · AIAI

    Netramark, CAMH win Ontario research award

    Netramark, CAMH win Ontario research award

    13
  14. Dec 16, 2025 · 12:00 · SVA

    From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

    From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

    14
← Newer Older →